Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Mydayis for the Treatment of Attention Deficit Hyperactivity Disorder

Drug (Brand / Generic)

Mydayis/amphetamine mixed salts

Developer

Shire

Therapy Class

CNS stimulant

Current Indication

Attention deficit hyperactivity disorder (ADHD)

Market Sector

CNS

Development Status

Approved in the US
Expand

Go Top